Skip to content
Get alerts
GovInfoNow
Lower risk Drug recall · FDA · Published August 26, 2019

EPI Health recalls minolira 135mg tablets: Failed dissolution specs

EPI Health recalls 135mg minol: Extended-release tablets may not dissolve properly, risking ineffective treatment. Check NDC 71403-102-05, lot T900093, exp 11/2020.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0120-2020DrugEPI Health ›
Take action

Contact the company

Recalling firmEPI Health, LLC134 Columbus St · Charleston, SC 29403-4809
✎ GovInfoNow plain-language explainer

EPI Health is recalling 135mg minolira extended-release tablets due to failed dissolution specifications. This means the medication might not release properly in the body, potentially leading to ineffective treatment. Read more at govinfonow.com/recall/38070-epi-health-recalls-minolira-135mg-tablets-failed-dissolution-specs.

Source Summary by GovInfoNow · govinfonow.com/recall/38070-epi-health-recalls-minolira-135mg-tablets-failed-dissolution-specs · Updated October 5, 2026 · FDA enforcement record: FDA #D-0120-2020

Cite this page

“EPI Health recalls minolira 135mg tablets: Failed dissolution specs.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38070-epi-health-recalls-minolira-135mg-tablets-failed-dissolution-specs. Based on FDA recall #D-0120-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0120-2020%22&limit=1).

EPI Health, LLC recalled minolira (minocycline hydrochloride) extended-release tablets due to failed dissolution specifications, the FDA said on Aug. 26, 2019.

How to tell if you have it

  • Brand: EPI Health
  • Product: minolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample Not for Sale 5 Tablets
  • NDC: 71403-102-05
  • Lot#: T900093
  • Expiration: 11/2020
  • Quantity: 1,626 bottles

The hazard

The recall addresses failed dissolution specifications for the drug product.

Context

GovInfoNow's records show EPI Health, LLC has one other recall on record since April 23, 2024. Other recent recalls of similar products include Teva Metoprolol Succinate Tablets Recall (Jan. 29, 2026), Inventia Chlorthalidone Recall (Sept. 3, 2026), and Ascend Minocycline Tablets Recall (June 1, 2026).

How to tell if you have this one

Check for the product name 'minolira (minocycline hydrochloride) extended-release tablets 135 mg', NDC 71403-102-05, lot number T900093, and expiration date 11/2020.

  • Brand
    EPI Health
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for NDC 71403-102-05, lot T900093, and expiration date 11/2020 on the packaging.

How this recall unfolded

Recall timeline

FDA terminated this recall 2 years after the firm started it.

1. Firm started the recall: Aug 26, 201912. FDA classified it Class III: Oct 2, 201923. Published in FDA’s Enforcement Report: Oct 2, 201934. FDA terminated the recall: Aug 18, 2021420192021
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

From the GovInfoNow team · based on the FDA notice · How we make summaries

Is this product available over the counter?

No, this product is prescription-only (Rx Only) and not available over the counter.

Similar recalls

Inventia Chlorthalidone Recall: Failed Dissolution Specs
Inventia HealthcareAscend Minocycline Tablets Recall: Failed Dissolution Test Risk
Ascend LaboratoriesInventia Healthcare Chlorthalidone Tablets Recall: Failed Dissolution Specifications
Inventia HealthcarePreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INC

Latest drug recalls

Apothecary Pharma LLC recalls Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary,
Apothecary Pharma · September 24, 2026Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026K.C. Pharmaceuticals, Inc. recalls Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO
Leader / TopCare / Crocodile Tears · September 11, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0120-2020 (August 26, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0120-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA